We presented in this study that two of the Yamanaka factors, Oct4 and c-Myc, can be used to convert the secretome of tumor cells into tumor-suppressive, while two other factors, Sox2 and Klf4, failed to induce tumor-suppressing capabilities. The gene discussed is SOX2; the disease is neoplasm.